{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:33:28Z","timestamp":1787236408546,"version":"build-2736575974"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,1,27]],"date-time":"2024-01-27T00:00:00Z","timestamp":1706313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,27]],"date-time":"2024-01-27T00:00:00Z","timestamp":1706313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the science and technology research program of Chongqing Education Commission of China","award":["KJ202302886967715"],"award-info":[{"award-number":["KJ202302886967715"]}]},{"DOI":"10.13039\/501100005230","name":"the natural science foundation of Chongqing","doi-asserted-by":"crossref","award":["CSTB2023NSCQ-BHX0225"],"award-info":[{"award-number":["CSTB2023NSCQ-BHX0225"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the school-level project fund of Chongqing Medical and Pharmaceutical College","award":["ygz2022102"],"award-info":[{"award-number":["ygz2022102"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Tumor-infiltrating lymphocytes (TILs) play a key role in regulating the host immune response and shaping tumor microenvironment. It has been previously shown that T cell infiltration in penile tumors was associated with clinical outcomes. However, few studies have reported the T cell receptor (TCR) repertoire in patients with penile cancer. In the present study, we evaluated the TCR repertoires in tumor and adjacent normal tissues from 22 patients with penile squamous cell carcinoma (PSCC). Analysis of the T cell receptor beta-variable (TRBV) and joining (TRBJ) genes usage and analysis of complementarity determining region 3 (CDR3) length distribution did not show significant differences between tumor and matched normal tissues. Moreover, analysis of the median Jaccard index indicated a limited overlap of TCR repertoire between these groups. Compared with normal tissues, a significantly lower diversity and higher clonality of TCR repertoire was observed in tumor samples, which was associated with clinical characteristics. Further analysis of transcriptional profiles demonstrated that tumor samples with high clonality showed increased expression of genes associated with CD8\u2009+\u2009T cells. In addition, we analyzed the TCR repertoire of CD4\u2009+\u2009T cells and CD8\u2009+\u2009T cells isolated from tumor tissues. We identified that expanded clonotypes were predominantly in the CD8\u2009+\u2009T cell compartment, which presented with an exhausted phenotype. Overall, we comprehensively compared TCR repertoire between penile tumor and normal tissues and demonstrated the presence of distinct T cell immune microenvironments in patients with PSCC.<\/jats:p>","DOI":"10.1007\/s00262-023-03615-z","type":"journal-article","created":{"date-parts":[[2024,1,27]],"date-time":"2024-01-27T06:02:21Z","timestamp":1706335341000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Characterization of T cell receptor repertoire in penile cancer"],"prefix":"10.1007","volume":"73","author":[{"given":"Junying","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yapeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xintao","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaojing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihua","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,27]]},"reference":[{"key":"3615_CR1","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/mou.0000000000000581","volume":"29","author":"A Douglawi","year":"2019","unstructured":"Douglawi A, Masterson TA (2019) Penile cancer epidemiology and risk factors: a contemporary review. Curr Opin Urol 29:145\u2013149. https:\/\/doi.org\/10.1097\/mou.0000000000000581","journal-title":"Curr Opin Urol"},{"key":"3615_CR2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12894-020-00628-z","volume":"20","author":"C Hu","year":"2020","unstructured":"Hu C, Bai Y, Li J et al (2020) Prognostic value of systemic inflammatory factors NLR, LMR, PLR and LDH in penile cancer. BMC Urol 20:57. https:\/\/doi.org\/10.1186\/s12894-020-00628-z","journal-title":"BMC Urol"},{"key":"3615_CR3","doi-asserted-by":"publisher","first-page":"594","DOI":"10.6004\/jnccn.2013.0075","volume":"11","author":"PE Clark","year":"2013","unstructured":"Clark PE, Spiess PE, Agarwal N et al (2013) Penile cancer: clinical practice guidelines in oncology. J Natl Compreh Cancer Netw JNCCN 11:594\u2013615. https:\/\/doi.org\/10.6004\/jnccn.2013.0075","journal-title":"J Natl Compreh Cancer Netw JNCCN"},{"key":"3615_CR4","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00345-008-0302-z","volume":"27","author":"MC Bleeker","year":"2009","unstructured":"Bleeker MC, Heideman DA, Snijders PJ, Horenblas S, Dillner J, Meijer CJ (2009) Penile cancer: epidemiology, pathogenesis and prevention. World J Urol 27:141\u2013150. https:\/\/doi.org\/10.1007\/s00345-008-0302-z","journal-title":"World J Urol"},{"key":"3615_CR5","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1038\/s41467-020-15980-9","volume":"11","author":"T Huang","year":"2020","unstructured":"Huang T, Cheng X, Chahoud J et al (2020) Effective combinatorial immunotherapy for penile squamous cell carcinoma. Nat Commun 11:2124. https:\/\/doi.org\/10.1038\/s41467-020-15980-9","journal-title":"Nat Commun"},{"issue":"31","key":"3615_CR6","doi-asserted-by":"publisher","first-page":"4872","DOI":"10.1200\/jco.22.02894","volume":"41","author":"HM de Vries","year":"2023","unstructured":"de Vries HM, Rafael TS, Gil-Jimenez A et al (2023) Atezolizumab with or without radiotherapy for advanced squamous cell carcinoma of the penis (the PERICLES study): a phase II trial. J Clin Oncol Off J Am Soc Clin Oncol 41(31):4872\u20134880. https:\/\/doi.org\/10.1200\/jco.22.02894","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"3615_CR7","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/334395a0","volume":"334","author":"MM Davis","year":"1988","unstructured":"Davis MM, Bjorkman PJ (1988) T-cell antigen receptor genes and T-cell recognition. Nature 334:395\u2013402. https:\/\/doi.org\/10.1038\/334395a0","journal-title":"Nature"},{"key":"3615_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/jcp.56.1.1","volume":"56","author":"E Hodges","year":"2003","unstructured":"Hodges E, Krishna MT, Pickard C, Smith JL (2003) Diagnostic role of tests for T cell receptor (TCR) genes. J Clin Pathol 56:1\u201311. https:\/\/doi.org\/10.1136\/jcp.56.1.1","journal-title":"J Clin Pathol"},{"key":"3615_CR9","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1101\/gr.092924.109","volume":"19","author":"JD Freeman","year":"2009","unstructured":"Freeman JD, Warren RL, Webb JR, Nelson BH, Holt RA (2009) Profiling the T-cell receptor beta-chain repertoire by massively parallel sequencing. Genome Res 19:1817\u20131824. https:\/\/doi.org\/10.1101\/gr.092924.109","journal-title":"Genome Res"},{"key":"3615_CR10","doi-asserted-by":"publisher","first-page":"4099","DOI":"10.1182\/blood-2009-04-217604","volume":"114","author":"HS Robins","year":"2009","unstructured":"Robins HS, Campregher PV, Srivastava SK, Wacher A, Turtle CJ, Kahsai O, Riddell SR, Warren EH, Carlson CS (2009) Comprehensive assessment of T-cell receptor beta-chain diversity in alphabeta T cells. Blood 114:4099\u20134107. https:\/\/doi.org\/10.1182\/blood-2009-04-217604","journal-title":"Blood"},{"key":"3615_CR11","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1158\/2326-6066.Cir-19-0398","volume":"8","author":"J Han","year":"2020","unstructured":"Han J, Duan J, Bai H et al (2020) TCR repertoire diversity of peripheral PD-1(+)CD8(+) T cells predicts clinical outcomes after immunotherapy in patients with non-small cell lung cancer. Cancer Immunol Res 8:146\u2013154. https:\/\/doi.org\/10.1158\/2326-6066.Cir-19-0398","journal-title":"Cancer Immunol Res"},{"key":"3615_CR12","doi-asserted-by":"publisher","first-page":"4098","DOI":"10.1038\/s41467-021-24343-x","volume":"12","author":"S Valpione","year":"2021","unstructured":"Valpione S, Mundra PA, Galvani E et al (2021) The T cell receptor repertoire of tumor infiltrating T cells is predictive and prognostic for cancer survival. Nat Commun 12:4098. https:\/\/doi.org\/10.1038\/s41467-021-24343-x","journal-title":"Nat Commun"},{"key":"3615_CR13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.lungcan.2021.09.017","volume":"162","author":"M Li","year":"2021","unstructured":"Li M, Zhang C, Deng S et al (2021) Lung cancer-associated T cell repertoire as potential biomarker for early detection of stage I lung cancer. Lung cancer (Amsterdam, Netherlands) 162:16\u201322. https:\/\/doi.org\/10.1016\/j.lungcan.2021.09.017","journal-title":"Lung cancer (Amsterdam, Netherlands)"},{"key":"3615_CR14","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41467-019-14273-0","volume":"11","author":"A Reuben","year":"2020","unstructured":"Reuben A, Zhang J, Chiou SH et al (2020) Comprehensive T cell repertoire characterization of non-small cell lung cancer. Nat Commun 11:603. https:\/\/doi.org\/10.1038\/s41467-019-14273-0","journal-title":"Nat Commun"},{"key":"3615_CR15","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12865-016-0177-5","volume":"17","author":"K Kitaura","year":"2016","unstructured":"Kitaura K, Shini T, Matsutani T, Suzuki R (2016) A new high-throughput sequencing method for determining diversity and similarity of T cell receptor (TCR) \u03b1 and \u03b2 repertoires and identifying potential new invariant TCR \u03b1 chains. BMC Immunol 17:38. https:\/\/doi.org\/10.1186\/s12865-016-0177-5","journal-title":"BMC Immunol"},{"key":"3615_CR16","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.cell.2014.10.026","volume":"159","author":"JJ Thome","year":"2014","unstructured":"Thome JJ, Yudanin N, Ohmura Y et al (2014) Spatial map of human T cell compartmentalization and maintenance over decades of life. Cell 159:814\u2013828. https:\/\/doi.org\/10.1016\/j.cell.2014.10.026","journal-title":"Cell"},{"key":"3615_CR17","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1038\/s41587-020-0505-4","volume":"38","author":"H Huang","year":"2020","unstructured":"Huang H, Wang C, Rubelt F, Scriba TJ, Davis MM (2020) Analyzing the Mycobacterium tuberculosis immune response by T-cell receptor clustering with GLIPH2 and genome-wide antigen screening. Nat Biotechnol 38:1194\u20131202. https:\/\/doi.org\/10.1038\/s41587-020-0505-4","journal-title":"Nat Biotechnol"},{"key":"3615_CR18","doi-asserted-by":"publisher","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","volume":"34","author":"S Chen","year":"2018","unstructured":"Chen S, Zhou Y, Chen Y, Gu J (2018) fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics (Oxford, England) 34:i884\u2013i890. https:\/\/doi.org\/10.1093\/bioinformatics\/bty560","journal-title":"Bioinformatics (Oxford, England)"},{"key":"3615_CR19","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.3317","volume":"12","author":"D Kim","year":"2015","unstructured":"Kim D, Langmead B, Salzberg SL (2015) HISAT: a fast spliced aligner with low memory requirements. Nat Methods 12:357\u2013360. https:\/\/doi.org\/10.1038\/nmeth.3317","journal-title":"Nat Methods"},{"key":"3615_CR20","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nbt.3122","volume":"33","author":"M Pertea","year":"2015","unstructured":"Pertea M, Pertea GM, Antonescu CM, Chang TC, Mendell JT, Salzberg SL (2015) StringTie enables improved reconstruction of a transcriptome from RNA-seq reads. Nat Biotechnol 33:290\u2013295. https:\/\/doi.org\/10.1038\/nbt.3122","journal-title":"Nat Biotechnol"},{"key":"3615_CR21","doi-asserted-by":"publisher","first-page":"eabd5778","DOI":"10.1126\/sciimmunol.abd5778","volume":"6","author":"P Gueguen","year":"2021","unstructured":"Gueguen P, Metoikidou C, Dupic T et al (2021) Contribution of resident and circulating precursors to tumor-infiltrating CD8(+) T cell populations in lung cancer. Sci Immunol 6:eabd5778. https:\/\/doi.org\/10.1126\/sciimmunol.abd5778","journal-title":"Sci Immunol"},{"key":"3615_CR22","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1093\/annonc\/mdw216","volume":"27","author":"AM Udager","year":"2016","unstructured":"Udager AM, Liu TY, Skala SL et al (2016) Frequent PD-L1 expression in primary and metastatic penile squamous cell carcinoma: potential opportunities for immunotherapeutic approaches. Ann Oncol Off J Eur Soc Med Oncol 27:1706\u20131712. https:\/\/doi.org\/10.1093\/annonc\/mdw216","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"3615_CR23","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.3892\/ol.2016.4142","volume":"11","author":"Z Liu","year":"2016","unstructured":"Liu Z, Han H, He X, Li S, Wu C, Yu C, Wang S (2016) Expression of the galectin-9-Tim-3 pathway in glioma tissues is associated with the clinical manifestations of glioma. Oncol Lett 11:1829\u20131834. https:\/\/doi.org\/10.3892\/ol.2016.4142","journal-title":"Oncol Lett"},{"key":"3615_CR24","doi-asserted-by":"publisher","first-page":"e0129119","DOI":"10.1371\/journal.pone.0129119","volume":"10","author":"S Punt","year":"2015","unstructured":"Punt S, Thijssen VL, Vrolijk J, de Kroon CD, Gorter A, Jordanova ES (2015) Galectin-1, -3 and -9 expression and clinical significance in squamous cervical cancer. PLoS ONE 10:e0129119. https:\/\/doi.org\/10.1371\/journal.pone.0129119","journal-title":"PLoS ONE"},{"key":"3615_CR25","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3390\/ijms19010323","volume":"19","author":"H Schulz","year":"2018","unstructured":"Schulz H, Kuhn C, Hofmann S, Mayr D, Mahner S, Jeschke U, Schmoeckel E (2018) Overall survival of ovarian cancer patients is determined by expression of galectins-8 and -9. Int J Mol Sci 19:323. https:\/\/doi.org\/10.3390\/ijms19010323","journal-title":"Int J Mol Sci"},{"key":"3615_CR26","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s00277-016-2911-8","volume":"96","author":"S Liu","year":"2017","unstructured":"Liu S, Zhang Q, Huang D et al (2017) Comprehensive assessment of peripheral blood TCR\u03b2 repertoire in infectious mononucleosis and chronic active EBV infection patients. Ann Hematol 96:665\u2013680. https:\/\/doi.org\/10.1007\/s00277-016-2911-8","journal-title":"Ann Hematol"},{"key":"3615_CR27","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1038\/s41467-017-01925-2","volume":"8","author":"I Gomez-Tourino","year":"2017","unstructured":"Gomez-Tourino I, Kamra Y, Baptista R, Lorenc A, Peakman M (2017) T cell receptor \u03b2-chains display abnormal shortening and repertoire sharing in type 1 diabetes. Nat Commun 8:1792. https:\/\/doi.org\/10.1038\/s41467-017-01925-2","journal-title":"Nat Commun"},{"key":"3615_CR28","doi-asserted-by":"publisher","first-page":"D1057","DOI":"10.1093\/nar\/gkz874","volume":"48","author":"DV Bagaev","year":"2020","unstructured":"Bagaev DV, Vroomans RMA, Samir J et al (2020) VDJdb in 2019: database extension, new analysis infrastructure and a T-cell receptor motif compendium. Nucleic Acids Res 48:D1057\u2013D1062. https:\/\/doi.org\/10.1093\/nar\/gkz874","journal-title":"Nucleic Acids Res"},{"key":"3615_CR29","doi-asserted-by":"publisher","first-page":"587014","DOI":"10.3389\/fimmu.2020.587014","volume":"11","author":"J Kidman","year":"2020","unstructured":"Kidman J, Principe N, Watson M, Lassmann T, Holt RA, Nowak AK, Lesterhuis WJ, Lake RA, Chee J (2020) Characteristics of TCR repertoire associated with successful immune checkpoint therapy responses. Front Immunol 11:587014. https:\/\/doi.org\/10.3389\/fimmu.2020.587014","journal-title":"Front Immunol"},{"key":"3615_CR30","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.122092","author":"AC Hopkins","year":"2018","unstructured":"Hopkins AC, Yarchoan M, Durham JN et al (2018) T cell receptor repertoire features associated with survival in immunotherapy-treated pancreatic ductal adenocarcinoma. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.122092","journal-title":"JCI Insight"},{"key":"3615_CR31","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13073-015-0242-3","volume":"7","author":"JJ Goronzy","year":"2015","unstructured":"Goronzy JJ, Qi Q, Olshen RA, Weyand CM (2015) High-throughput sequencing insights into T-cell receptor repertoire diversity in aging. Genome Med 7:117. https:\/\/doi.org\/10.1186\/s13073-015-0242-3","journal-title":"Genome Med"},{"key":"3615_CR32","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.gpb.2018.10.005","volume":"17","author":"X Wang","year":"2019","unstructured":"Wang X, Zhang B, Yang Y, Zhu J, Cheng S, Mao Y, Feng L, Xiao T (2019) Characterization of distinct T cell receptor repertoires in tumor and distant non-tumor tissues from lung cancer patients. Genom Proteom Bioinform 17:287\u2013296. https:\/\/doi.org\/10.1016\/j.gpb.2018.10.005","journal-title":"Genom Proteom Bioinform"},{"key":"3615_CR33","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ctrv.2017.11.007","volume":"63","author":"R Tokunaga","year":"2018","unstructured":"Tokunaga R, Zhang W, Naseem M, Puccini A, Berger MD, Soni S, McSkane M, Baba H, Lenz HJ (2018) CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation - a target for novel cancer therapy. Cancer Treat Rev 63:40\u201347. https:\/\/doi.org\/10.1016\/j.ctrv.2017.11.007","journal-title":"Cancer Treat Rev"},{"key":"3615_CR34","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00428-014-1713-4","volume":"466","author":"P Lohneis","year":"2015","unstructured":"Lohneis P, Boral S, Kaufmann AM, Lehmann A, Schewe C, Dietel M, Anagnostopoulos I, J\u00f6hrens K (2015) Human papilloma virus status of penile squamous cell carcinoma is associated with differences in tumour-infiltrating T lymphocytes. Virchows Archiv Int J Pathol 466:323\u2013331. https:\/\/doi.org\/10.1007\/s00428-014-1713-4","journal-title":"Virchows Archiv Int J Pathol"},{"key":"3615_CR35","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/cmi.2014.134","volume":"12","author":"M Attaf","year":"2015","unstructured":"Attaf M, Huseby E, Sewell AK (2015) \u03b1\u03b2 T cell receptors as predictors of health and disease. Cell Mol Immunol 12:391\u2013399. https:\/\/doi.org\/10.1038\/cmi.2014.134","journal-title":"Cell Mol Immunol"},{"key":"3615_CR36","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1007\/s00262-018-2237-6","volume":"67","author":"YB Jin","year":"2018","unstructured":"Jin YB, Luo W, Zhang GY et al (2018) TCR repertoire profiling of tumors, adjacent normal tissues, and peripheral blood predicts survival in nasopharyngeal carcinoma. Cancer Immunol Immunother CII 67:1719\u20131730. https:\/\/doi.org\/10.1007\/s00262-018-2237-6","journal-title":"Cancer Immunol Immunother CII"},{"key":"3615_CR37","doi-asserted-by":"publisher","first-page":"e1219010","DOI":"10.1080\/2162402x.2016.1219010","volume":"5","author":"Y Chen","year":"2016","unstructured":"Chen Y, Xu Y, Zhao M, Liu Y, Gong M, Xie C, Wu H, Wang Z (2016) High-throughput T cell receptor sequencing reveals distinct repertoires between tumor and adjacent non-tumor tissues in HBV-associated HCC. Oncoimmunology 5:e1219010. https:\/\/doi.org\/10.1080\/2162402x.2016.1219010","journal-title":"Oncoimmunology"},{"key":"3615_CR38","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.euf.2015.09.007","volume":"2","author":"NJ Choudhury","year":"2016","unstructured":"Choudhury NJ, Kiyotani K, Yap KL et al (2016) Low T-cell receptor diversity, high somatic mutation burden, and high neoantigen load as predictors of clinical outcome in muscle-invasive bladder cancer. Eur Urol Focus 2:445\u2013452. https:\/\/doi.org\/10.1016\/j.euf.2015.09.007","journal-title":"Eur Urol Focus"},{"key":"3615_CR39","doi-asserted-by":"publisher","first-page":"537735","DOI":"10.3389\/fonc.2021.537735","volume":"11","author":"H Yang","year":"2021","unstructured":"Yang H, Wang Y, Jia Z et al (2021) Characteristics of T-cell receptor repertoire and correlation with EGFR mutations in all stages of lung cancer. Front Oncol 11:537735. https:\/\/doi.org\/10.3389\/fonc.2021.537735","journal-title":"Front Oncol"},{"key":"3615_CR40","doi-asserted-by":"publisher","first-page":"e1003292","DOI":"10.1371\/journal.pmed.1003292","volume":"17","author":"R Sanz-Pamplona","year":"2020","unstructured":"Sanz-Pamplona R, Melas M, Maoz A et al (2020) Lymphocytic infiltration in stage II microsatellite stable colorectal tumors: a retrospective prognosis biomarker analysis. PLoS Med 17:e1003292. https:\/\/doi.org\/10.1371\/journal.pmed.1003292","journal-title":"PLoS Med"},{"key":"3615_CR41","doi-asserted-by":"publisher","first-page":"4394","DOI":"10.3390\/cancers13174394","volume":"13","author":"J Lecuelle","year":"2021","unstructured":"Lecuelle J, Boidot R, Mananet H et al (2021) TCR clonality and genomic instability signatures as prognostic biomarkers in high grade serous ovarian cancer. Cancers. 13:4394. https:\/\/doi.org\/10.3390\/cancers13174394","journal-title":"Cancers."},{"key":"3615_CR42","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/nature13954","volume":"515","author":"PC Tumeh","year":"2014","unstructured":"Tumeh PC, Harview CL, Yearley JH et al (2014) PD-1 blockade induces responses by inhibiting adaptive immune resistance. Nature 515:568\u2013571. https:\/\/doi.org\/10.1038\/nature13954","journal-title":"Nature"},{"key":"3615_CR43","doi-asserted-by":"publisher","first-page":"eaah3560","DOI":"10.1126\/scitranslmed.aah3560","volume":"9","author":"W Roh","year":"2017","unstructured":"Roh W, Chen PL, Reuben A et al (2017) Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance. Sci Transl Med 9:eaah3560. https:\/\/doi.org\/10.1126\/scitranslmed.aah3560","journal-title":"Sci Transl Med"},{"key":"3615_CR44","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.3390\/cancers12071796","volume":"12","author":"C Chu","year":"2020","unstructured":"Chu C, Yao K, Lu J, Zhang Y, Chen K, Lu J, Zhang CZ, Cao Y (2020) Immunophenotypes based on the tumor immune microenvironment allow for unsupervised penile cancer patient stratification. Cancers 12:1796. https:\/\/doi.org\/10.3390\/cancers12071796","journal-title":"Cancers"},{"key":"3615_CR45","doi-asserted-by":"publisher","first-page":"972021","DOI":"10.3389\/fimmu.2022.972021","volume":"13","author":"DS Kravtsov","year":"2022","unstructured":"Kravtsov DS, Erbe AK, Sondel PM, Rakhmilevich AL (2022) Roles of CD4+ T cells as mediators of antitumor immunity. Front Immunol 13:972021. https:\/\/doi.org\/10.3389\/fimmu.2022.972021","journal-title":"Front Immunol"},{"key":"3615_CR46","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.bbrc.2015.01.069","volume":"458","author":"Q Zhang","year":"2015","unstructured":"Zhang Q, Jia Q, Deng T, Song B, Li L (2015) Heterogeneous expansion of CD4+ tumor-infiltrating T-lymphocytes in clear cell renal cell carcinomas. Biochem Biophys Res Commun 458:70\u201376. https:\/\/doi.org\/10.1016\/j.bbrc.2015.01.069","journal-title":"Biochem Biophys Res Commun"},{"key":"3615_CR47","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ebiom.2017.07.018","volume":"22","author":"I Gon\u00e7alves Silva","year":"2017","unstructured":"Gon\u00e7alves Silva I, Yasinska IM, Sakhnevych SS et al (2017) The Tim-3-galectin-9 secretory pathway is involved in the immune escape of human acute myeloid Leukemia cells. EBioMedicine 22:44\u201357. https:\/\/doi.org\/10.1016\/j.ebiom.2017.07.018","journal-title":"EBioMedicine"},{"key":"3615_CR48","doi-asserted-by":"publisher","first-page":"7005","DOI":"10.2147\/ott.S170385","volume":"11","author":"Y He","year":"2018","unstructured":"He Y, Cao J, Zhao C, Li X, Zhou C, Hirsch FR (2018) TIM-3, a promising target for cancer immunotherapy. Onco Targets Ther 11:7005\u20137009. https:\/\/doi.org\/10.2147\/ott.S170385","journal-title":"Onco Targets Ther"},{"key":"3615_CR49","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1016\/j.gendis.2022.05.020","volume":"10","author":"Y Lv","year":"2023","unstructured":"Lv Y, Ma X, Ma Y, Du Y, Feng J (2023) A new emerging target in cancer immunotherapy: Galectin-9 (LGALS9). Genes Dis 10:2366\u20132382. https:\/\/doi.org\/10.1016\/j.gendis.2022.05.020","journal-title":"Genes Dis"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-023-03615-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-023-03615-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-023-03615-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T23:32:37Z","timestamp":1708471957000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-023-03615-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,27]]},"references-count":49,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["3615"],"URL":"https:\/\/doi.org\/10.1007\/s00262-023-03615-z","relation":{},"ISSN":["1432-0851"],"issn-type":[{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,27]]},"assertion":[{"value":"26 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Research Ethics Committee of Daping Hospital of the Third Military Medical University. All the participants provided written informed consent and all the experiments were conducted in accordance with the guidelines of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"24"}}